Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC)
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Computed Tomography (CT) - Guided Brachytherapy Versus Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Songyou Granule and Transarterial Chemoembolization for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE1
Anatomical Right Posterior Sectionectomy of the Liver by IOUS-Guided Finger Compression
- Status
- UNKNOWN
- Phase
- N/A
A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication
- Status
- COMPLETED
- Phase
- N/A
Relationship Between Polymorphism of Heat Shock Protein 70 Gene and Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients After Resection of Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
Tumor Growth Factors in Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
SBRT + TACE for Primary Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- NA
Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Effect of I/R Injuries by Pringle Manoeuvre on the Prognosis of HCC Patients After Curative Hepatectomy
- Status
- COMPLETED
- Phase
- NA
The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1